Connect with us

INDUSTRIAL HEMP

A World-Renowned Clinician And Oncologist Discuss The Potential Success Of The Upcoming Pharmacyte Biotech Inc. (OTCMKTS:PMCB) Clinical Trial

Published

on

Pharmacyte Biotech Inc. (OTCMKTS:PMCB) has published an interview by Dr. Manuel Hidalgo. The world-renowned clinician and oncologist were live on “The Big Biz Show. He was discussing his role in the upcoming clinical trial, which will use PharmaCyte’s Technology. He is currently the overseer of the Beth Israel Deaconess Medical Center (BIDMC) clinical cancer programs.

As the Principal Investigator of the trial and with his ultimate involvement, Hidalgo says that they have developed a strategy and a design. The two should provide a clear guideline on how PharmaCyte intends to embrace patients who have pancreatic cancer.

There is the potential for success following two earlier trials

Hidalgo is excited about the company’s new approach and its commitment to change the handling of tumors. He says that PharmaCyte’s therapy for pancreatic cancer makes a lot of sense and it is worth exploring. The joy is in having a new treatment accomplish a goal of meeting the unmet needs.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

“As investigators, we are always interested in and excited about new approaches to treating pancreatic cancer—the third most deadly cancer and soon to become the second most deadly,” he quotes.

There is a lot of enthusiasm about the success of the upcoming trial. The success of the previous trials has triggered the interesting feeling, which demonstrates great promise. Hence will all systems in place, Hidalgo claims that PharmaCyte’s study has so much potential.

PharmaCyte’s technology will become a platform for developing many other therapies

PharmaCyte is so passionate about the development of cellular therapies for cancer and diabetes. It is envisioning to work closely with clinicians, oncologists, and hospitals, which handle pancreatic cancer patients. That said, it is likely that PharmaCyte’s technology could play a double role in the development of several other therapies.

PharmaCyte’s therapy is novel and complex. It is worth noting that the first-line therapy no longer provides standard benefits to patients. However, there is a need for compliance with the regulatory requirements for purposes of approval. Hidalgo explains that a successful clinical trial must involve a CRO with substantial experience with trials. The CRO must have demonstrated a track record of regulatory compliance.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

INDUSTRIAL HEMP2 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP2 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP2 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP2 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP2 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP2 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP2 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP2 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP2 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP2 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play